Abiopharma

News list

Steinmetz Mari 🟡 adjusted position in 1.0K shares of KOHLS Corp (KSS) at $12.50 Transaction Date: Mar 25, 2026 | Filing ID: 000033

Full text

News bot March 26, 2026, 8:08 p.m.
🔍 Steinmetz Mari (Executive)

Company: KOHLS Corp (KSS)

Report Date: 2026-03-25
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 312
- Total shares sold: 1,319
Detailed Transactions and Holdings:
- Acquired 312 shares of Common Stock (Direct)
  Date: 2026-03-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 219,062.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 862 shares of Common Stock at $12.35 per share (Direct)
  Date: 2026-03-25 | Code: F | equity_swap_involved: 0 | shares_owned_after: 218,200.00 | transaction_form_type: 4 | Footnotes: F2
- Sold 457 shares of Common Stock at $12.5 per share (Direct)
  Date: 2026-03-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 217,743.00 | transaction_form_type: 4 | Footnotes: F3, F4
Footnotes:
- F1: Issuance of additional shares representing dividend equivalent amount on vested restricted stock units.
- F2: Represents shares used to satisfy tax withholding obligations upon vesting of restricted stock units and corresponding dividend equivalent amounts under the Company's Long-Term Compensation Plan.
- F3: Includes 201,443 unvested restricted stock units.
- F4: The reported sale of an aggregate of 457 shares occurred automatically pursuant to a previously disclosed Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025.